Scipher Medicine logoSM

Scipher Medicine

Verified

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. Healthcare Biotech

About Scipher Medicine

Scipher Medicine is tracked on 100Xfounder as a healthcare company, founded in 2014, based in Boston, Massachusetts, USA, currently mapped to the Series D stage. Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. Healthcare Biotech

Profile snapshot: Founders linked: Scipher Medicine Team. Funding tracked: $110.00M. Hiring focus: Open Roles. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

  • Scipher Medicine appears in the 100Xfounder startup directory import feed.

Why it Matters

Scipher Medicine is worth tracking because its funding history is already mapped here, including a $110.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Scipher Medicine Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $110.00MLast Round: Series D Khosla Ventures, $110M Series D in 2022All Rounds: 1
  • Series D | Khosla Ventures, $110M Series D in 2022

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: June 1, 2026

Scipher Medicine research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

  • Company summary

    Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. Healthcare Biotech

  • Founders covered

    Scipher Medicine Team

  • Market position

    Healthcare | Series D | Boston, Massachusetts, USA

  • Newsroom signal

    No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.

  • Funding signal

    $110.00M

Best next clicks

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Scipher Medicine.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Scipher Medicine

Common questions people ask about this profile.

What is Scipher Medicine?

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. Healthcare Biotech

Who founded Scipher Medicine?

Scipher Medicine is associated with Scipher Medicine Team on 100Xfounder.

Where is Scipher Medicine located?

Scipher Medicine is listed in Boston, Massachusetts, USA.

What stage is Scipher Medicine in?

Scipher Medicine is currently mapped to Series D. Funding context: Khosla Ventures, $110M Series D in 2022

What is the latest funding round of Scipher Medicine?

Scipher Medicine's latest tracked round is Series D Khosla Ventures, $110M Series D in 2022. Total tracked rounds: 1.

Is Scipher Medicine hiring now?

Scipher Medicine hiring status: Open Roles.

What technologies does Scipher Medicine use?

Scipher Medicine is associated with Python, GCP, BigQuery, and React.

Is Scipher Medicine verified on 100Xfounder?

Yes. Scipher Medicine is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with Scipher Medicine founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.